BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 36882040)

  • 21. The Complement System Component C5a Produces Thermal Hyperalgesia via Macrophage-to-Nociceptor Signaling That Requires NGF and TRPV1.
    Shutov LP; Warwick CA; Shi X; Gnanasekaran A; Shepherd AJ; Mohapatra DP; Woodruff TM; Clark JD; Usachev YM
    J Neurosci; 2016 May; 36(18):5055-70. PubMed ID: 27147658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anaphylatoxin receptor promiscuity for commonly used complement C5a peptide agonists.
    Li XX; Clark RJ; Woodruff TM
    Int Immunopharmacol; 2021 Nov; 100():108074. PubMed ID: 34454293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aptamers that bind to the human complement component receptor hC5aR1 interfere with hC5aR1 interaction to its hC5a ligand.
    Kumar PKR
    Mol Biol Rep; 2018 Oct; 45(5):851-864. PubMed ID: 29981048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The C5a/C5aR1 axis controls the development of experimental allergic asthma independent of LysM-expressing pulmonary immune cells.
    Wiese AV; Ender F; Quell KM; Antoniou K; Vollbrandt T; König P; Köhl J; Laumonnier Y
    PLoS One; 2017; 12(9):e0184956. PubMed ID: 28931049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knockout mouse models reveal the contributions of G protein subunits to complement C5a receptor-mediated chemotaxis.
    van den Bos E; Ambrosy B; Horsthemke M; Walbaum S; Bachg AC; Wettschureck N; Innamorati G; Wilkie TM; Hanley PJ
    J Biol Chem; 2020 May; 295(22):7726-7742. PubMed ID: 32332099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure and characterization of a high affinity C5a monoclonal antibody that blocks binding to C5aR1 and C5aR2 receptors.
    Colley CS; Popovic B; Sridharan S; Debreczeni JE; Hargeaves D; Fung M; An LL; Edwards B; Arnold J; England E; Eghobamien L; Sivars U; Flavell L; Renshaw J; Wickson K; Warrener P; Zha J; Bonnell J; Woods R; Wilkinson T; Dobson C; Vaughan TJ
    MAbs; 2018 Jan; 10(1):104-117. PubMed ID: 28952876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C5a- and ASP-mediated C5L2 activation, endocytosis and recycling are lost in S323I-C5L2 mutation.
    Cui W; Simaan M; Laporte S; Lodge R; Cianflone K
    Mol Immunol; 2009 Sep; 46(15):3086-98. PubMed ID: 19615750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C5aR1 interacts with TLR2 in osteoblasts and stimulates the osteoclast-inducing chemokine CXCL10.
    Mödinger Y; Rapp A; Pazmandi J; Vikman A; Holzmann K; Haffner-Luntzer M; Huber-Lang M; Ignatius A
    J Cell Mol Med; 2018 Dec; 22(12):6002-6014. PubMed ID: 30247799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bidirectional Crosstalk between C5a Receptors and the NLRP3 Inflammasome in Macrophages and Monocytes.
    Haggadone MD; Grailer JJ; Fattahi F; Zetoune FS; Ward PA
    Mediators Inflamm; 2016; 2016():1340156. PubMed ID: 27382187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of functionally selective C5aR2 ligands: novel modulators of C5a signalling.
    Croker DE; Monk PN; Halai R; Kaeslin G; Schofield Z; Wu MC; Clark RJ; Blaskovich MA; Morikis D; Floudas CA; Cooper MA; Woodruff TM
    Immunol Cell Biol; 2016 Sep; 94(8):787-95. PubMed ID: 27108698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammatory responses induced by lipopolysaccharide are amplified in primary human monocytes but suppressed in macrophages by complement protein C5a.
    Seow V; Lim J; Iyer A; Suen JY; Ariffin JK; Hohenhaus DM; Sweet MJ; Fairlie DP
    J Immunol; 2013 Oct; 191(8):4308-16. PubMed ID: 24043889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The complement factor 5a receptor 1 has a pathogenic role in chronic inflammation and renal fibrosis in a murine model of chronic pyelonephritis.
    Choudhry N; Li K; Zhang T; Wu KY; Song Y; Farrar CA; Wang N; Liu CF; Peng Q; Wu W; Sacks SH; Zhou W
    Kidney Int; 2016 Sep; 90(3):540-54. PubMed ID: 27370410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C5a/C5aR1 mediates IMQ-induced psoriasiform skin inflammation by promoting IL-17A production from γδ-T cells.
    Zheng QY; Xu F; Yang Y; Sun DD; Zhong Y; Wu S; Li GQ; Gao WW; Wang T; Xu GL; Liang SJ
    FASEB J; 2020 Aug; 34(8):10590-10604. PubMed ID: 32557852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C5L2 is required for C5a-triggered receptor internalization and ERK signaling.
    Hsu WC; Yang FC; Lin CH; Hsieh SL; Chen NJ
    Cell Signal; 2014 Jul; 26(7):1409-19. PubMed ID: 24631530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complement C5a-Induced Changes in Neutrophil Morphology During Inflammation.
    Denk S; Taylor RP; Wiegner R; Cook EM; Lindorfer MA; Pfeiffer K; Paschke S; Eiseler T; Weiss M; Barth E; Lambris JD; Kalbitz M; Martin T; Barth H; Messerer DAC; Gebhard F; Huber-Lang MS
    Scand J Immunol; 2017 Sep; 86(3):143-155. PubMed ID: 28671713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The C5a/C5aR1 axis promotes progression of renal tubulointerstitial fibrosis in a mouse model of renal ischemia/reperfusion injury.
    Peng Q; Wu W; Wu KY; Cao B; Qiang C; Li K; Sacks SH; Zhou W
    Kidney Int; 2019 Jul; 96(1):117-128. PubMed ID: 31029505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional Analysis of a Novel Complement C5a Receptor 1-Blocking Monoclonal Antibody.
    Cyranka L; Mariegaard I; Skjødt MO; Bayarri-Olmos R; Mollnes TE; Garred P; Rosbjerg A
    J Innate Immun; 2023; 15(1):836-849. PubMed ID: 37952515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C5a receptors C5aR1 and C5aR2 mediate opposing pathologies in a mouse model of melanoma.
    Nabizadeh JA; Manthey HD; Panagides N; Steyn FJ; Lee JD; Li XX; Akhir FNM; Chen W; Boyle GM; Taylor SM; Woodruff TM; Rolfe BE
    FASEB J; 2019 Oct; 33(10):11060-11071. PubMed ID: 31298935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C5aR2 receptor: The genomic twin of the flamboyant C5aR1.
    Das A; Gupta PK; Rana S
    J Cell Biochem; 2022 Nov; 123(11):1841-1856. PubMed ID: 35977039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The C5aR1 complement receptor: A novel immunomodulator of insulin action in skeletal muscle.
    Shah DS; McNeilly AD; McCrimmon RJ; Hundal HS
    Cell Signal; 2024 Jan; 113():110944. PubMed ID: 37890688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.